Intake of trans-fats among US youth declined from 1999-2000 to 2009-2010

OBJECTIVE: To analyse how much the intake of trans-fatty acids (TFA), an important dietary risk factor for CVD, changed among US children and adolescents over a period of time when food regulations that reduced the presence of TFA in the food supply were enacted.

DESIGN: Regression models were used to estimate changes in levels of TFA in plasma and other CVD risk factors among US children and adolescents from 1999-2000 to 2009-2010.

SETTING: USA.

PARTICIPANTS: Nationally representative sample of children (aged 6-11 years) and adolescents (aged 12-19 years) who participated in the 1999-2000 and 2009-2010 cycles of the National Health and Nutrition Examination Survey.

RESULTS: Levels of plasma TFA declined significantly by an average of 61·9 % from 1999-2000 to 2009-2010. The average decline in a TFA commonly found in partially hydrogenated oils (elaidic acid, 67·2 %) was larger than the average decline in a TFA naturally occurring in ruminant animals (vaccenic acid, 60·5 %). Significant improvements in a variety of other CVD risk factors (LDL- and HDL-cholesterol, TAG, systolic and diastolic blood pressure, C-reactive protein) were also observed.

CONCLUSIONS: Between the two time points, 1999-2000 and 2009-2010, there were substantial decreases in plasma TFA levels and improvements in several other important CVD risk factors in the population of US children and adolescents.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:23

Enthalten in:

Public health nutrition - 23(2020), 6 vom: 09. Apr., Seite 1103-1107

Sprache:

Englisch

Beteiligte Personen:

Restrepo, Brandon J [VerfasserIn]

Links:

Volltext

Themen:

9007-41-4
Adolescents
C-Reactive Protein
CVD
Children
Cholesterol, HDL
Cholesterol, LDL
Journal Article
National Health and Nutrition Examination Survey
Research Support, U.S. Gov't, Non-P.H.S.
Trans Fatty Acids
Trans-fatty acids
Triglycerides
USA

Anmerkungen:

Date Completed 30.03.2021

Date Revised 19.06.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1017/S1368980019003367

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM305180533